Concepedia

Author

Henri Doods

Boehringer Ingelheim (Germany)

Also Known As

H DOODS, H Doods, H N Doods, H. Doods, H. N. DOODS, H. N. Doods, H.N. Doods, Henri Doods, Henri N Doods, Henri N. Doods

127

Publications

6.3K

Citations

38

H-Index

95

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Mount Sinai Medical CenterJeonbuk National UniversityUniversity of Applied Sciences BiberachPharmazeutische Fabrik Dr. Reckeweg (Germany)
HD

About

Henri Doods is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

54

2.8K

2

Health Sciences

11

12

449

3

Social Sciences

10

10

699

4

Natural Sciences

3

3

128

5

Public Health

2

2

70

Henri Doods

×

85

Publications

5K

Citations

37

H-Index

YearCitations

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

Henri Doods, Gerhard Hallermayer, Dongmei Wu,

British Journal of Pharmacology

2000

467

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226

K Rudolf, Wolfgang Eberlein, Wolfhard Engel,

European Journal of Pharmacology

1994

374

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

H. Wieland, W. Engel, Wolfgang Eberlein,

British Journal of Pharmacology

1998

257

Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired

Rémi Quirion, Amy Wilson, Wayne Rowe,

Journal of Neuroscience

1995

205

BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist

Henri Doods, Wolfram Gaida, H. Wieland,

European Journal of Pharmacology

1999

189

The First Selective Agonist for the Neuropeptide YY5Receptor Increases Food Intake in Rats

Chiara Cabrele, Michael Langer, Reto Bader,

Journal of Biological Chemistry

2000

182

Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833

Bing Hu, Henri Doods, Rolf‐Detlef Treede,

Pain

2009

135

Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.

Henri Doods, Wolfgang Wienen, Michael Entzeroth,

Journal of Pharmacology and Experimental Therapeutics

1995

127

Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release

Peter King, Gareth Williams, Henri Doods,

European Journal of Pharmacology

2000

126

Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat

Kenneth A. Petersen, Steffen Birk, Henri Doods,

British Journal of Pharmacology

2004

125

Page 1